ask="31.35"
ask_size="400"
average_daily_volume="221042"
bid="N/A"
bid_size="N/A"
book_value="3.79"
change="-0.01"
change_from_200_day_moving_average="4.97"
change_from_50_day_moving_average="2.65"
change_from_52_week_high="-2.12"
change_From_52_week_low="17.01"
change_in_percent="-0.03%"
close="31.13"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.09"
ebitda="-37.24M"
eps_estimate_current_year="-2.36"
eps_estimate_next_quarter="-0.54"
eps_estimate_next_year="-2.97"
ex_dividend_date="N/A"
float_shares="15981000"
high="31.57"
high_52_weeks="33.25"
last_trade_date="3/13/2017"
last_trade_price="31.13"
last_trade_size="2356"
last_trade_time="4:00pm"
low="30.07"
low_52_weeks="14.12"
market_capitalization="667.18M"
moving_average_200_day="26.16"
moving_average_50_day="28.48"
name="Aclaris Therapeutics
Inc."
notes="N/A"
one_year_target_price="26.33"
open="31.19"
pe_ratio="N/A"
peg_ratio="-0.22"
percent_change_from_200_day_moving_average="+18.99%"
percent_change_from_50_day_moving_average="+9.32%"
percent_change_from_52_week_high="-6.38%"
percent_change_from_52_week_low="+120.47%"
previous_close="31.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.22"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="21432000"
short_ratio="7.75"
stock_exchange="NMS"
symbol="ACRS"
volume="93401"
weeks_range_52="14.12 - 33.25"
